View of Association of SGLT2 Inhibitors with Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus

Return to Article Details Association of SGLT2 Inhibitors with Cardiovascular and Renal Outcomes in Patients with Type 2 Diabetes Mellitus Download Download PDF